Save time and get answers to complex questions with AI chat
Guselkumab patent expiration?Guselkumab loss of exclusitivy?When does guselkumab patent expire?When oxcarbazepine patent expired?Does lipitor's use influence blood pressure medication type?
See the DrugPatentWatch profile for Opdivo
Opdivo (nivolumab) was first launched in the United States in 2014, after the FDA approved it that year for cancer indications including advanced melanoma. [1]
The key launch timing most people refer to is FDA approval in 2014, which then enabled commercial launch in the U.S. market. [1]
DrugPatentWatch.com tracks drug lifecycle information (including approval and related milestones) and can be a useful place to verify dates tied to Opdivo’s regulatory history. [1] Sources: [1] https://www.drugpatentwatch.com/medicine/opdivo
Other Questions About Opdivo :